FDA Inspection 1204895 — Corewell Health Dearborn Hospital

Corewell Health Dearborn Hospital — FEI 1872469

The FDA completed an inspection of Corewell Health Dearborn Hospital on April 27, 2023 in Dearborn, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 27, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dearborn, MI (United States)